# Phase 2 Scleroderma, Systemic trials recruiting: 26 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials in phase 2 for Scleroderma, Systemic that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Scleroderma, Systemic trials: 26 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/scleroderma-systemic

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 26
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07925619 | Efficacy and Safety Study of L608 in Patients With Systemic Sclerosis-associated Digital Ulcers | Pharmosa Biopharm Inc. | Phase 2 | Not yet recruiting | Systemic Sclerosis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925619) |
| November 9, 2026 | NCT07925242 | FAPI PET in Systemic Sclerosis Interstitial Lung Disease | University of California, Los Angeles | Phase 2 | Not yet recruiting | Systemic Sclerosis (SSc), Scleroderma, Interstitial Lung Disease With Systemic Sclerosis | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925242) |
| November 4, 2026 | NCT07916324 | Hyaluronidase Injections for Sclerodactyly in Patients With Scleroderma | Stanford University | Phase 2 | Not yet recruiting | Scleroderma, Sclerodactyly, Systemic Sclerosis | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916324) |
| September 25, 2026 | NCT07842523 | Obinutuzumab in Systemic Sclerosis | Assistance Publique - Hôpitaux de Paris | Phase 2 | Not yet recruiting | Systemic Sclerosis in Adults | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842523) |
| September 18, 2026 | NCT07827742 | Rituximab vs Placebo for Maintenance in Systemic Sclerosis - Interstitial Lung Disease | Assistance Publique - Hôpitaux de Paris | Phase 2 | Not yet recruiting | Systemic Sclerosis in Adults | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07827742) |
| September 15, 2026 | NCT07821398 | Hyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Interstitial Lung Disease, Pulmonary Hypertension, Systemic Sclerosis | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821398) |
| August 5, 2026 | NCT07748000 | A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks | Liquidia Technologies, Inc. | Phase 2 | Not yet recruiting | Raynaud's Phenomenon Secondary to Systemic Sclerosis | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07748000) |
| August 4, 2026 | NCT07745725 | A Phase II Study of TollB-001 Tablets in Systemic Sclerosis | Toll Biotech Co. Ltd. (Beijing) | Phase 2 | Not yet recruiting | Systemic Sclerosis (SSc) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745725) |
| July 29, 2026 | NCT07734012 | Mycophenolate After Stem Cell Transplant for Systemic Sclerosis | Ottawa Hospital Research Institute | Phase 2 | Not yet recruiting | Systemic Sclerosis (SSc) | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734012) |
| March 25, 2026 | NCT07493395 | Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy | University Hospital, Montpellier | Phase 2 | Recruiting | Scleroderma, Systemic | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07493395) |
| January 8, 2026 | NCT07326033 | Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients... | University Hospital, Toulouse | Phase 2 | Not yet recruiting | Systemic Scleroderma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07326033) |
| July 2, 2025 | NCT07047690 | A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis | Galderma R&D | Phase 2 | Recruiting | Systemic Sclerosis | 162 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07047690) |
| May 25, 2025 | NCT06991114 | AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing... | Artiva Biotherapeutics, Inc. | Phase 2 | Recruiting | Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc), Rheumatoid... | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06991114) |
| May 1, 2025 | NCT06954597 | Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis | Topadur Pharma AG | Phase 2 | Recruiting | Digital Ulcers in Systemic Sclerosis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06954597) |
| February 14, 2025 | NCT06827977 | A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis | The University of Texas Health Science Center, Houston | Phase 2 | Recruiting | Constipation, Bloating | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06827977) |
| January 27, 2025 | NCT06794008 | BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases | Peking University People's Hospital | Phase 2 | Recruiting | Systemic Lupus Erythematosus, Inflammatory Myopathy, Systemic Sclerosis (SSc), ANCA-associated Vasculitis, IgG4-Related... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06794008) |
| November 4, 2024 | NCT06672822 | Intralesional Injection of STS in Treatment of Calcinosis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Systemic Sclerosis (SSc), Dermatomyositis, Mixed Connective Tissue Disease (MCTD), Calcinosis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06672822) |
| January 8, 2024 | NCT06195072 | Platform Clinical Study for Conquering Scleroderma | Scleroderma Research Foundation, Inc. | Phase 2 | Recruiting | Interstitial Lung Disease Due to Systemic Disease, Scleroderma | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06195072) |
| June 7, 2023 | NCT05892614 | Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung... | aTyr Pharma, Inc. | Phase 2 | Recruiting | Interstitial Lung Disease | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05892614) |
| March 27, 2023 | NCT05785065 | Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 2 | Recruiting | Systemic Sclerosis With Lung Involvement, Systemic Sclerosis, Interstitial Lung Disease | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05785065) |
| August 31, 2021 | NCT05029336 | Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases | Sponsor not shown (see the record) | Phase 2 | Recruiting | Systemic Lupus Erythematosus, Systemic Sclerosis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05029336) |
| August 3, 2021 | NCT04986605 | Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 2 | Recruiting | Diffuse Cutaneous Systemic Sclerosis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04986605) |
| March 10, 2021 | NCT04789850 | Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis | Assistance Publique - Hôpitaux de Paris | Phase 2 | Recruiting | Systemic Sclerosis | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04789850) |
| April 22, 2020 | NCT04356755 | Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma. | University Hospital, Toulouse | Phase 2 | Recruiting | Systemic Sclerosis | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04356755) |
| August 14, 2018 | NCT03630211 | Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease, Pulmonary Hypertension | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03630211) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assistance Publique - Hôpitaux de Paris | 3 |
| University Hospital, Toulouse | 2 |
| Pharmosa Biopharm Inc. | 1 |
| Scleroderma Research Foundation, Inc. | 1 |
| Topadur Pharma AG | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Peking University People's Hospital | 1 |
| University of California, Los Angeles | 1 |
| Artiva Biotherapeutics, Inc. | 1 |
| Stanford University | 1 |
| Ottawa Hospital Research Institute | 1 |
| aTyr Pharma, Inc. | 1 |
| Liquidia Technologies, Inc. | 1 |
| [Galderma R&D](https://specstream.ai/data/clinical-trials/company/galderma-r-and-d) | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| University Hospital, Montpellier | 1 |
| The University of Texas Health Science Center, Houston | 1 |
| University Hospital, Limoges | 1 |
| Toll Biotech Co. Ltd. (Beijing) | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 10 |
| France | 9 |
| Canada | 3 |
| Switzerland | 2 |
| China | 2 |
| Brazil | 1 |
| Bulgaria | 1 |
| Germany | 1 |
| Italy | 1 |
| Poland | 1 |
| Portugal | 1 |
| Romania | 1 |
| Serbia | 1 |
| Spain | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Farm equipment repair companies in the United States](https://specstream.ai/data/businesses/farm-equipment-repair-companies/united-states)
- [Insulation contractors in the United States](https://specstream.ai/data/businesses/insulation-contractors/united-states)
- [Office cleaning companies in the United States](https://specstream.ai/data/businesses/office-cleaning-companies/united-states)
- [Retaining wall suppliers in the United States](https://specstream.ai/data/businesses/retaining-wall-suppliers/united-states)
- [Uniform stores in the United States](https://specstream.ai/data/businesses/uniform-stores/united-states)
- [B2B medical support companies in the United States](https://specstream.ai/data/businesses/b2b-medical-support-companies/united-states)
